Further, miR-181c promotes CCA cell proliferation, chemoresistance, and metastasis by targeting NDRG2, and overexpression of miR-181c is associated with poor overall survival in patients with CCA [86]. Here, NDRG2 is linked to cholangiocarcinoma.